Neutrophil toxicity and primary prophylaxis in diffuse large B cell lymphoma treated with R-CHOP

被引：0
|
作者：
Naqi, N. [1 ]
Khatak, J. [1 ]
机构：
[1] Combined Mil Hosp, Rawalpindi, Pakistan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19548
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma
    Miura, Katsuhiro
    Takahashi, Hiromichi
    Nakagawa, Masaru
    Hamada, Takashi
    Uchino, Yoshihito
    Iizuka, Kazuhide
    Ohtake, Shimon
    Iriyama, Noriyoshi
    Hatta, Yoshihiro
    Nakamura, Hideki
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (06) : 583 - 595
  • [32] Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOP
    Mondello, Patrizia
    Mian, Michael
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 333 - 344
  • [33] Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Sinclair, Natalie
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    LEUKEMIA RESEARCH, 2013, 37 (04) : 386 - 391
  • [34] Use of the Lymphgen Tool in a Cohort of Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP
    Jackson, Ryan
    Perry, Anamarija
    Herrera, Alex
    Bedell, Victoria
    Murata-Collins, Joyce
    Rahimi, Nina
    Pillai, Raju
    Chan, Wing
    Weisenburger, Dennis
    Song, Joo
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 845 - 846
  • [35] Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP
    Yoh, Kyung Ah
    Lee, Ho Sup
    Park, Lee Chun
    Lee, Eun Mi
    Shin, Seong Hoon
    Ye, Byeong Jin
    Moon, Joon Ho
    Jo, Jae-Cheol
    Lee, Won Sik
    Shin, Ho-Jin
    Oh, Sun Young
    Kim, Yang Soo
    BLOOD, 2013, 122 (21)
  • [36] Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy
    Hong, Junshik
    Woo, Hyun Seon
    Kim, Hyunchul
    Ahn, Hee Kyung
    Sym, Sun Jin
    Park, Jinny
    Ahn, Jeong Yeal
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    CANCER SCIENCE, 2014, 105 (12): : 1569 - 1575
  • [37] PROGNOSTIC SIGNIFICANCE OF IMMUNOHISTOCHEMICAL MARKERS IN R-CHOP TREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
    Picleanu, A. -M.
    Patrascu, S.
    Mogoanta, L.
    HAEMATOLOGICA, 2017, 102 : 826 - 827
  • [38] Improving R-CHOP in diffuse large B-cell lymphoma is still a challenge
    Jardin, Fabrice
    LANCET ONCOLOGY, 2019, 20 (05) : 605 - 606
  • [39] Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma
    Gouni, Sushanth
    Strati, Paolo
    Toruner, Gokce
    Aradhya, Akanksha
    Landgraf, Ralf
    Bilbao, Daniel
    Vega, Francisco
    Agarwal, Nitin Kumar
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1302 - 1313
  • [40] Comparison between CHOP-like and R-CHOP in diffuse large B cell and follicular lymphoma
    Oliver, Carolina
    Guillermo, Cecilia
    Martinez, Paula
    Diaz, Lilian
    REVISTA MEDICA DE CHILE, 2013, 141 (07) : 844 - 852
12345